Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.


​ASCO GU 2017: Atezolizumab in mUCC

A selection of posters from the 2017 Genitourinary Cancers Symposium is highlighted in a series of interviews.

Speaker: Daniel Petrylak

Poster: B290 - Atezolizumab (atezo) in patients with metastatic urothelial carcinoma (mUC): A 2-year clinical update from a phase Ia study

  • Sponsors

    This program is editorially independent and is financially supported by:

Related items